Autolus Therapeutics PLC (NASDAQ:AUTL)

12.00
Delayed Data
As of Sep 29
 -0.89 / -6.90%
Today’s Change
3.00
Today|||52-Week Range
17.19
-9.09%
Year-to-Date
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during ESMO event
Sep 18 / Seeking Alpha - Paid Partner Content
Seeking Alpha Catalyst Watch
Sep 11 / Seeking Alpha - Paid Partner Content
Autolus' AUTO3 shows promising results in blood cancer study
Sep 18 / Seeking Alpha - Paid Partner Content
Autolus Therapeutics Plc (AUTL) Investor Presentation - Slideshow
Sep 11 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close12.89
Today’s open12.46
Day’s range12.00 - 12.55
Volume74,567
Average volume (3 months)181,054
Market cap$667.2M
Data as of 3:59pm ET, 09/29/2020

Growth & Valuation

Earnings growth (last year)-102.99%
Earnings growth (this year)+6.17%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.71

Competitors

 Today’s
change
Today’s
% change
PGENPrecigen Inc-0.04-1.12%
IMGNImmunoGen Inc-0.02-0.70%
KDMNKadmon Holdings Inc-0.04-1.06%
TLRYTilray Inc+0.01+0.21%
Data as of 4:10pm ET, 09/29/2020

Financials

Next reporting dateNovember 5, 2020
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$0.00
Annual profit (last year)-$124.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
London, Greater London

Forecasts